Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III study of SAGE-217 in postpartum depression meets primary and secondary endpoints

Jan. 8, 2019

Etrasimod demonstrates long-term clinical remission in phase II OLE study for ulcerative colitis

Jan. 8, 2019

Forbius initiates phase I trial of AVID-200 in solid tumors

Jan. 8, 2019

Epclusa approved in Japan for HCV

Jan. 8, 2019

Homology Medicines nominates in vivo gene editing development candidate for PKU

Jan. 8, 2019

Incyte begins phase I study of INCB-086550 in advanced solid tumors

Jan. 8, 2019

SH-498 presented as a promising anti-BMI-1 compound for colorectal cancer

Jan. 8, 2019

Final safety results presented from phase I study of BT-11 in healthy volunteers

Jan. 8, 2019

BlackThorn Therapeutics offers pipeline update

Jan. 8, 2019

BCAR3 as novel biomarker of prognosis in patients with multiple myeloma

Jan. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...